016580 — Whanin Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Market Cap
KR₩190bn
Enterprise Value
KR₩132bn
Revenue
KR₩260bn

Annual balance sheet for Whanin Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	116,956	146,043	87,292	78,066	52,062
Net Total Accounts Receivable
Net Total Receivables	64,106	63,120	72,326	78,947	75,709
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	214,355	242,412	197,422	212,101	201,297
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	45,822	46,869	109,854	131,211	149,218
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	329,560	353,189	369,375	401,227	424,706
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	26,725	30,900	31,750	40,028	42,376
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	33,445	36,249	35,863	43,019	48,704
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	296,115	316,939	333,511	358,207	376,002
Total Liabilities & Shareholders' Equity	329,560	353,189	369,375	401,227	424,706
Total Common Shares Outstanding